![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 4, 2124-2130, January 24, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Hormel Institute, University of Minnesota,
Austin, Minnesota 55912
Cyclooxygenases (COX) are rate-limiting enzymes
that catalyze the conversion of arachidonic acid to prostaglandins,
which are involved in many physiological and pathophysiological
responses. COX-2, one of two isoforms of COX, was recently found to
play an important role in carcinogenesis in many cell and tissue types. COX-2 inhibitors, which belong to the family of nonsteroidal
anti-inflammatory drugs, are believed to be effective in many
biological activities such as tumor chemoprevention because of their
inhibition of COX-2. However, in the present study we found that both
piroxicam, a general COX inhibitor, and NS-398, a COX-2 selective
inhibitor, effectively suppressed the activation of transcription
factor activator protein 1 (AP-1) induced by ultraviolet B (UVB) or
12-O-tetradecanoylphorbol-13-acetate in mouse epidermal JB6
cells. These COX-2 inhibitors could also inhibit
12-O-tetradecanoylphorbol-13-acetate-induced cell
transformation. UVB significantly increased AP-1 activity in
Cox-2
/
fibroblasts transfected with an AP-1
luciferase reporter gene, and this increase was blocked by NS-389 or
piroxicam. In JB6, Cox-2
/
, or wild-type
Cox-2+/+ cells, both NS-398 and piroxicam
inhibited UVB-induced phosphorylation of c-Jun NH2-terminal
kinases, the kinases that activate the AP-1/c-Jun complex. Based on our
results, we propose that the inhibition of AP-1 activity by COX-2
inhibitors NS-398 or piroxicam may occur by a mechanism that is
independent of COX-2.
To whom correspondence should be addressed: The Hormel Institute,
University of Minnesota, 801 16th Ave. N.E., Austin, MN 55912. Tel.:
507-437-9600; Fax: 507-437-9606; E-mail: zgdong@hi.umn.edu.
This article has been cited by other articles:
![]() |
H. H. Kim, C. M. Shin, C.-H. Park, K. H. Kim, K. H. Cho, H. C. Eun, and J. H. Chung Eicosapentaenoic acid inhibits UV-induced MMP-1 expression in human dermal fibroblasts J. Lipid Res., August 1, 2005; 46(8): 1712 - 1720. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Patel, K. Subbaramaiah, B. Du, M. Chang, P. Yang, R. A. Newman, C. Cordon-Cardo, H. T. Thaler, and A. J. Dannenberg Celecoxib Inhibits Prostate Cancer Growth: Evidence of a Cyclooxygenase-2-Independent Mechanism Clin. Cancer Res., March 1, 2005; 11(5): 1999 - 2007. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Eibl, Y. Takata, L. G. Boros, J. Liu, Y. Okada, H. A. Reber, and O. J. Hines Growth Stimulation of COX-2-Negative Pancreatic Cancer by a Selective COX-2 Inhibitor Cancer Res., February 1, 2005; 65(3): 982 - 990. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Trouba and D. R. Germolec Micromolar Concentrations of Sodium Arsenite Induce Cyclooxygenase-2 Expression and Stimulate p42/44 Mitogen-Activated Protein Kinase Phosphorylation in Normal Human Epidermal Keratinocytes Toxicol. Sci., June 1, 2004; 79(2): 248 - 257. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |